[HTML][HTML] Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical …
D Couriel, PA Carpenter, C Cutler… - Biology of Blood and …, 2006 - Elsevier
The Ancillary Therapy and Supportive Care Working Group had 3 goals:(1) to establish
guidelines for ancillary therapy and supportive care in chronic graft-versus-host disease …
guidelines for ancillary therapy and supportive care in chronic graft-versus-host disease …
Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific
Background Herpes zoster (HZ) is a prevalent viral disease that inflicts substantial morbidity
and associated healthcare and socioeconomic burdens. Current treatments are not fully …
and associated healthcare and socioeconomic burdens. Current treatments are not fully …
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
We previously reported that the Charlson Comorbidity Index (CCI) was useful for predicting
outcomes in patients undergoing allogeneic hematopoietic cell transplantation (HCT) …
outcomes in patients undergoing allogeneic hematopoietic cell transplantation (HCT) …
[HTML][HTML] National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. The 2014 ancillary therapy and …
PA Carpenter, CL Kitko, S Elad, MED Flowers… - Biology of Blood and …, 2015 - Elsevier
Abstract The 2006 National Institutes of Health (NIH) Consensus paper presented
recommendations by the Ancillary Therapy and Supportive Care Working Group to support …
recommendations by the Ancillary Therapy and Supportive Care Working Group to support …
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
AJ Ullmann, M Schmidt-Hieber, H Bertz, WJ Heinz… - Annals of …, 2016 - Springer
Infectious complications after allogeneic haematopoietic stem cell transplantation (allo-HCT)
remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases …
remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases …
Comorbidity and disease status–based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic …
ML Sorror, BM Sandmaier, BE Storer… - Journal of Clinical …, 2007 - ascopubs.org
Purpose Retrospective studies have shown similar survival among patients with acute
myeloid leukemia (AML) and myelodysplasia (MDS) after nonmyeloablative compared with …
myeloid leukemia (AML) and myelodysplasia (MDS) after nonmyeloablative compared with …
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning …
ML Sorror, MB Maris, B Storer, BM Sandmaier… - Blood, 2004 - ashpublications.org
We have carried out HLA-matched unrelated donor hematopoietic cell transplantation (HCT)
after nonmyeloablative conditioning in patients with hematologic malignancies who were …
after nonmyeloablative conditioning in patients with hematologic malignancies who were …
Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic …
M Sorror, B Storer, BM Sandmaier, DG Maloney… - Cancer, 2008 - Wiley Online Library
BACKGROUND Elderly and medically infirm cancer patients are increasingly offered
allogeneic nonmyeloablative hematopoietic cell transplantation (HCT). A better …
allogeneic nonmyeloablative hematopoietic cell transplantation (HCT). A better …
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic …
ML Sorror, BE Storer, DG Maloney… - Blood, The Journal …, 2008 - ashpublications.org
Allogeneic conventional hematopoietic cell transplantation (HCT) can be curative treatment
for lymphoid malignancies, but it has been characterized by high nonrelapse mortality …
for lymphoid malignancies, but it has been characterized by high nonrelapse mortality …
Impfen bei Immundefizienz: Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen.(III) Impfen bei hämatologischen und …
HJ Laws, U Baumann, C Bogdan, G Burchard… - 2020 - Springer
In Deutschland leben aktuell circa 4 Mio. Menschen, die in ihrem Leben eine
Krebserkrankung diagnostiziert bekommen haben [171]. Im Zeitraum von 1980–2017 …
Krebserkrankung diagnostiziert bekommen haben [171]. Im Zeitraum von 1980–2017 …